Clinical trial
Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic…
NCT00199719 · University Hospital, Limoges, Other · Completed
Key facts
| NCT number | NCT00199719 |
|---|---|
| Title | Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM |
| Official title | Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C Non 2 -3 Genotype naïve Patients Treated With a 12 Weeks Bitherapy of Peginterferon Alpha 2a-ribavirin, and Followed by a Tritherapy of Peginterferon Alpha 2a-ribavirin-amantadine for 36 Weeks |
| Acronym | CINAM |
| Lead sponsor | University Hospital, Limoges, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Ribavirine |
| Enrollment | 30 |
| Start date | Jun 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 30, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: